Purification of Adeno-Associated Virus (AAV) by continuous Chromatography

Lead Participant: COBRA BIOLOGICS LIMITED

Abstract

The project aims to increase yields of Adeno-Associated Viral (AAV) vectors for human gene therapy studies through the improved purification processes and through the adoption of continuous chromatography approaches. The project aims to develop purification processes with improved yields and robustness that can be readily scaled to those required for in-market requirements at a reduced cost of goods than is currently being achieved for these vectors, addressing the critical needs to increase the supply and costs of these medicines.

Lead Participant

Project Cost

Grant Offer

COBRA BIOLOGICS LIMITED £601,675 £ 361,005
 

Participant

INNOVATE UK
PALL EUROPE LIMITED £447,765 £ 223,882
COBRA BIOLOGICS LIMITED
CELL THERAPY CATAPULT LIMITED £449,450 £ 449,450
CELL THERAPY CATAPULT SERVICES LIMITED

Publications

10 25 50